Insider Trading News: Synergy Pharmaceuticals Inc (SGYP), Celgene Corporation (CELG), Cytosorbents Corp (CTSO), Amedica Corporation (AMDA)


Recently, various executives have taken part in insider trading activity for the stocks of Synergy Pharmaceuticals Inc (NASDAQ:SGYP), Celgene Corporation (NASDAQ:CELG), Cytosorbents Corp (NASDAQ:CTSO), and Amedica Corporation (NASDAQ:AMDA).

Synergy Pharmaceuticals Inc

Director Alan Joslyn divested entire direct stake in Synergy Pharmaceuticals, which amounted to 13,754 common shares. The insider sold the shares for $99,347 in three transactions dated September 11. Joslyn joined the board of directors on October 8, 2009. He is currently the Chief Executive Officer of Edusa Pharmaceuticals, a privately held biotechnology company.

Click Here to see the performance of Synergy Pharmaceuticals insiders.

Celgene Corporation

Director Gilla Kaplan disposed 15,000 Celgene shares (14% of total stake), valued at $1,836,750, on September 10. Kaplan now holds 88,485 of the company’s shares that are valued at $10,852,685. According to TipRanks.com, which measures corporate insiders’ success based on their transactions, Gilla Kaplan has an average return of -5.3% and a 25.0% success rate. Kaplan is ranked #21396 out of 34014 corporate insiders.

Click Here to see the performance of Celgene insiders.

Cytosorbents Corp

Director Al Kraus unloaded 10,000 Cytosorbents shares (15% of total stake), valued at $72,600, in a transaction dated September 10. The shares were sold via automatic sale program. Kraus now holds 55,746 of the company’s shares that are valued at $379,630.

Click Here to see the performance of Cytosorbents insiders.

Amedica Corporation

Principal Accounting Officer and Vice President of Finance Ty Lombardi purchased 25,000 Amedica shares, valued $10,000 on September 10. After completion of the transaction, Lombardi owns 51,971 shares, worth $21,048.

Click Here to see the performance of Amedica insiders.